Login / Signup

Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients.

Hanzada Mohamed El MaghrabiAhmed Yahia ElmowafyAyman Fathi RefaieMohammed Adel ElbasionyGamal Elsayed ShihaLionel RostaingMohamed Adel Bakr
Published in: International urology and nephrology (2019)
DAAs were highly efficacious and safely treated genotype-4 HCV-infected KTRs and had no significant adverse effects on graft function/survival.
Keyphrases
  • hepatitis c virus infection
  • hepatitis c virus
  • emergency department
  • combination therapy
  • free survival
  • newly diagnosed
  • adverse drug
  • antiretroviral therapy